Fresenius SE upgraded to Overweight from Equal Weight at Morgan Stanley

Morgan Stanley upgraded Fresenius SE to Overweight from Equal Weight with a price target of EUR 39, up from EUR 34. The company has reached a “tipping point on portfolio simplification,” where its Kabi and Helios assets should underpin improved future performance, further supported by self-help initiatives, the analyst tells investors in a research note.